Umb Bank, N.A. Teva Pharmaceutical Industries LTD Transaction History

Umb Bank, N.A.

$6.26 Billion
Q2 2025

A detailed history of Umb Bank, N.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Umb Bank, N.A. holds 3,271 shares of TEVA stock, worth $63,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,271

Previous 2,779 17.7%

Holding current value

$63,522

Previous $46,000 17.39%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$12.82 - $18.15 $6,307 - $8,929	492 Added 17.7%	3,271 $54,000
Q1 2025 Apr 14, 2025	BUY	$14.67 - $22.01 $733 - $1,100	50 Added 1.83%	2,779 $42,000
Q4 2024 Jan 16, 2025	BUY	$16.43 - $22.77 $4,764 - $6,603	290 Added 11.89%	2,729 $60,000
Q3 2024 Oct 08, 2024	BUY	$15.81 - $18.96 $32,679 - $39,190	2,067 Added 555.65%	2,439 $43,000
Q2 2024 Jul 29, 2024	SELL	$12.78 - $17.4 $38 - $52	-3 Reduced 0.8%	372 $6,000
Q4 2023 Jan 23, 2024	SELL	$8.12 - $10.63 $1,664 - $2,179	-205 Reduced 35.34%	375 $3,000
Q3 2023 Oct 18, 2023	BUY	$7.48 - $10.7 $2,805 - $4,012	375 Added 182.93%	580 $5,000
Q2 2023 Jul 25, 2023	SELL	$7.2 - $9.47 $3,636 - $4,782	-505 Reduced 71.13%	205 $1,000
Q1 2023 Apr 11, 2023	BUY	$8.36 - $11.37 $4,221 - $5,741	505 Added 246.34%	710 $6,000
Q2 2022 Jul 20, 2022	SELL	$7.38 - $10.4 $8,140 - $11,471	-1,103 Reduced 84.33%	205 $2,000
Q1 2022 Apr 22, 2022	SELL	$7.33 - $9.39 $623 - $798	-85 Reduced 6.1%	1,308 $12,000
Q4 2021 Feb 09, 2022	BUY	$7.9 - $10.19 $11,004 - $14,194	1,393 New	1,393 $11,000

Others Institutions Holding TEVA

# of Institutions

653

Shares Held

659M

Call Options Held

30.1M

Put Options Held

16.4M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $21.6B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account